Suppr超能文献

先天性血栓性血小板减少性紫癜中ADAMTS13基因突变,既往报道其血管性血友病因子裂解蛋白酶活性正常。

ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity.

作者信息

Savasan Sureyya, Lee Soon-Ki, Ginsburg David, Tsai Han-Mou

机构信息

Children's Hospital of Michigan, Division of Hematology/Oncology, Wayne State University, Detroit, MI, USA.

出版信息

Blood. 2003 Jun 1;101(11):4449-51. doi: 10.1182/blood-2002-12-3796. Epub 2003 Feb 6.

Abstract

Deficiency of von Willebrand factor (VWF) cleaving protease ADAMTS13 is associated with the development of thrombotic thrombocytopenic purpura (TTP). A case of congenital TTP that was previously reported to have normal ADAMTS13 activity was analyzed at the molecular level. Reanalysis of plasma VWF cleaving protease activity using a different assay revealed that the patient had less than 0.1 U/L ADAMTS13 protease activity, while the parents were both partially deficient. Sequence analysis of DNA amplified by polymerase chain reaction showed that the patient was homozygous for a novel TT deletion in exon 15 of the ADAMTS13 gene resulting in a frameshift, while both parents were heterozygous for the same mutation. Taken together with other recent reports, all the cases of hereditary TTP studied by DNA sequence analysis to date appear to be due to mutations within the ADAMTS13 gene.

摘要

血管性血友病因子(VWF)裂解蛋白酶ADAMTS13的缺乏与血栓性血小板减少性紫癜(TTP)的发生有关。对先前报道的一例先天性TTP进行了分子水平分析,该病例的ADAMTS13活性曾被认为正常。使用不同检测方法对血浆VWF裂解蛋白酶活性进行重新分析发现,该患者的ADAMTS13蛋白酶活性低于0.1 U/L,而其父母均为部分缺乏。通过聚合酶链反应扩增的DNA序列分析表明,该患者在ADAMTS13基因第15外显子中存在一个新的TT缺失,导致移码突变,且为纯合子,而其父母均为该突变的杂合子。结合其他近期报道,迄今为止通过DNA序列分析研究的所有遗传性TTP病例似乎均由ADAMTS13基因内的突变所致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验